ACTRN12616001138471
Recruiting
未知
Developing novel blood-based DNA and RNA biomarkers to detect adenocarcinoma by assessing the blood from people.aged 25 years and older, who have recently been diagnosed with prostate, breast, lung, pancreas, gallbladder, biliary tract, duodenal, periampullary, oesophageal or stomach cancer.
Erin Symonds0 sites1,300 target enrollmentAugust 22, 2016
ConditionsProstate cancerBreast CancerOesophageal cancerGastric (stomach) cancerLung cancerPancreatic cancerGallbladder cancerBiliary tree cancerDuodenal cancerPeriampullary cancerCancer - BreastCancer - ProstateCancer - Oesophageal (gullet)Cancer - StomachCancer - Lung - Non small cellCancer - PancreaticCancer - Other cancer types
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Prostate cancer
- Sponsor
- Erin Symonds
- Enrollment
- 1300
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Male or female aged 25 years or more
- •\-Known diagnosis of primary adenocarcinoma of the prostate, breast, lung, pancreas, oesophagus, stomach or digestive tract cancers (of any pathological stage)
- •\-Ability and willingness to undergo venepuncture procedure
- •\-Patients must be capable of providing satisfactory informed consent
Exclusion Criteria
- •\-Unable to provide informed consent.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Study to identify blood-derived biomarkers indicative for initiation and progression of X-linked adrenoleukodystrophyHealthy volunteersE71.3Disorders of fatty-acid metabolismDRKS00022930Center for Brain Research, Medical University of Vienna400
Recruiting
Not Applicable
Discover specific biomarkers that enable early diagnosis of colon cancer and develop early diagnosis technology for colon cancer using those biomarkers.NeoplasmsKCT0009054Korea Basic Science Institute120
Recruiting
Not Applicable
Utilizing Novel Blood RNA Biomarkers as a Diagnostic Tool in the Identification of Long COVID-19Long COVIDNCT06311435MaxWell Clinic, PLC224
Recruiting
Not Applicable
Identification of a New Blood Biomarker for the Diagnosis and Prognosis of LiposarcomasLiposarcomaAtypical Lipomatous TumorNCT04224064Institut du Cancer de Montpellier - Val d'Aurelle158
Completed
Not Applicable
Identification of novel serum biomarkers enabling differential diagnosis of non-alcoholic fatty liver diseaseon-alcoholic fatty liver diseaseJPRN-UMIN000033887Toho University27